Reta vs Tirz Dosage: How the Two Weekly Schedules Compare

Retatrutide and tirzepatide are both once-weekly injected peptides, but their dosing schedules are not interchangeable. Tirzepatide is FDA-approved and titrated from 2.5 mg up to a 15 mg weekly ceiling, while retatrutide is still investigational and was studied at 1 mg to 12 mg per week. Dose decisions for either drug belong with a licensed prescriber, not a forum thread.

Dosing Differences at a Glance

Tirzepatide (Mounjaro, Zepbound) and retatrutide look similar on paper: same weekly injection schedule, same slow build-up, same goal of keeping stomach side effects manageable. The real differences show up in how high each drug can go and how much evidence backs the number.

Tirzepatide Dosage: The Approved Step-Up Schedule

Tirzepatide dosing does not change based on body weight; the label uses fixed weekly doses. The 2.5 mg starting dose exists to let the body adjust, and it is not meant to drive weight loss by itself.

1. Weeks 1 to 4: 2.5 mg once weekly.
2. Weeks 5 onward: 5 mg once weekly.
3. Every 4 weeks after that: the dose may increase by 2.5 mg if side effects stay manageable.
4. Maximum: 15 mg once weekly.

Reaching 15 mg takes about 20 weeks of step-ups. Moving faster than the label allows tends to bring more nausea, vomiting, and constipation, which is why prescribers rarely rush it.

Anyone comparing reta vs mounjaro dosage should remember that Mounjaro is simply the brand name for tirzepatide, so the same 15 mg ceiling applies.

Retatrutide Dosage in Clinical Trials

Retatrutide has no approved dose because it has no approval. The most detailed human data come from a Phase 2 trial that tested 1 mg, 4 mg, 8 mg, and 12 mg once weekly, plus a 2 mg arm that used a gentler ramp.

• Participants increased their dose roughly every 4 weeks.
• At 48 weeks, the 12 mg group lost about 24% of body weight on average.
• Lower doses produced smaller average reductions, which points to a dose-response relationship rather than one ideal number.

There is no reta 15 mg dosage chart for the simple reason that 12 mg is the highest weekly dose with published Phase 2 results. Phase 3 trials are still running, and a final label, if one is ever granted, could look different.

Why Milligrams Do Not Transfer Between Reta and Tirz

Dose numbers only compare when two drugs work the same way. Retatrutide adds a glucagon receptor component that tirzepatide does not have, and the two were tested in separate trials with different titration rules, durations, and patient populations.

A 12 mg dose of retatrutide is not equivalent to a 12 mg dose of tirzepatide, and a 5 mg dose of one does not map cleanly onto a 5 mg dose of the other.

That is also why the question is reta or tirz better for weight loss has no clean answer yet: the drugs have never been compared head to head in a randomized trial.

Threads on tirzepatide vs semaglutide dosage reddit show how often dose strength, potency, and personal experience get blended into a single number that does not translate to anyone else.

Side Effects and Titration Rules

Both drugs share a class-typical side effect profile: nausea, vomiting, diarrhea, constipation, reduced appetite, and occasional injection-site reactions. Most of these ease as the body adapts, and slower titration is the main lever for keeping them manageable.

Seek medical attention for severe or persistent abdominal pain, signs of dehydration, or symptoms of gallbladder problems. Retatrutide's added glucagon activity has been linked to small increases in heart rate and liver enzyme changes in trial data, which is one reason it remains under study.

Combination use raises extra questions. There is no clinical trial evidence to support a reta and mots-c stack dosage, and stacking unapproved peptides raises the odds of interactions that nobody is tracking.

Safety, Access, and Next Steps

Retatrutide is not FDA-approved for human use in the United States. What is sold online as retatrutide is usually a research chemical with no guarantee of purity, sterility, or actual content, and it is not intended for human consumption.

Tirzepatide is available by prescription, and access depends on insurance coverage, supply, and state rules around compounded versions. A prescriber can walk through the step-up schedule, monitor labs, and adjust when side effects become hard to tolerate.

• Do not use weight-loss drugs without medical supervision, especially with a history of pancreatitis, gallbladder disease, or if you are pregnant or planning pregnancy.
• Never convert a tirzepatide dose into a retatrutide dose on your own; there is no validated conversion.
• Keep expectations realistic, because individual results vary widely and average trial numbers are not a personal forecast.

The short version: retatrutide and tirzepatide are titrated on different scales, backed by different levels of evidence, and used under very different legal conditions. A clinician who knows your history is the right person to set any dose.